Business
LB Pharmaceuticals to Participate in Upcoming June Investor Events
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, J
About this update from Lb Pharmaceuticals Inc
[{"type":"image","alt":"LB Pharmaceuticals Inc","displaySize":"","headline":null,"caption":"LB Pharmaceuticals Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":136,"url":"https://media.zenfs.com/en/globenewswire.com/2840fbb85165e0ffde8f4da0174483e2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WMouKAmWk2ehxmDB5xPULw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5MA--/https://media.zenfs.com/en/globenewswire.com/2840fbb85165e0ffde8f4da0174483e2","width":300,"height":136},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/WMouKAmWk2ehxmDB5xPULw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5MA--/https://media.zenfs.com/en/globenewswire.com/2840fbb85165e0ffde8f4da0174483e2","width":300,"height":136}},"lazy":false},{"type":"text","content":"NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences:","length":443,"tagName":"p"},{"type":"text","content":"Jefferies Global Healthcare Conference","length":38,"tagName":"p"},{"type":"text","content":"Date: Thursday, June 4, 2026","length":28,"tagName":"p"},{"type":"text","content":"Time: 2:35 p.m. ET","length":18,"tagName":"p"},{"type":"text","content":"H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference ","length":63,"tagName":"p"},{"type":"text","content":"Date: Tuesday, June 16, 2026","length":28,"tagName":"p"},{"type":"text","content":"Time: Presentation available on the LB Pharmaceuticals website","length":62,"tagName":"p"},{"type":"text","content":"The webcasts for the presentation and fireside chat will be available on the “Investors” page section under the “Events” section of the Company’s website at https://ir.lbpharma.us/, where a replay of the webcasts will be archived.","length":240,"tagName":"p"},{"type":"text","content":"About LB Pharmaceuticals","length":24,"tagName":"p"},{"type":"text","content":"LB Pharmaceuticals is a late-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, adjunctive treatment of major d...